A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy

Although androgen deprivation therapy for prostate cancer is associated with an increased risk of osteoporosis, the optimal timing and schedule of zoledronic acid has not been identified. This phase II trial randomized 44 men beginning androgen deprivation therapy to 3 schedules of zoledronic acid a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lang, Joshua M., Wallace, Marianne, Becker, Jordan T., Eickhoff, Jens C., Buehring, Bjoern, Binkley, Neil, Staab, Mary Jane, Wilding, George, Liu, Glenn, Malkovsky, Miroslav, McNeel, Douglas G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3836858/
https://ncbi.nlm.nih.gov/pubmed/23835291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2013.04.029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados